Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 83 results for "glenmark generics inc"

Glenmark receives US FDA approval for generic Mycolog-II cream...

Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (FDA) for nystatin and triamcinolone acetonide cream USP, 100,000 units/gram and 1 mg/g, the generic version of Mycolog-II ... PharmaBiz, 1 month ago
Glenmark receives approval for Nystatin Cream HT Syndication, 1 month ago

2 images for "glenmark generics inc"

Financial Express, 2 months ago
Money Control, 2 months ago
Pharmacy Times

Generic Product News (October 2016) »

TRIAMCINOLONE ACETONIDE CREAM USP, 0.1% MARKETED BY: Glenmark Pharmaceuticals, Inc COMPARE TO: Kenalog Cream, 0.1% (Delcor Asset Corporation) INDICATION: Glenmark Pharmaceuticals, Inc, has been granted final approval by the FDA for Triamcinolone ...
 Pharmacy Times1 month ago Generic Product News (November 2016) »  Pharmacy Times3 weeks ago Glenmark Pharma gets ANDA approval for Nystatin and Triamcinolone Acetonide Cream USP, 100,000 units/gram and 1 mg/g  India Infoline1 month ago 10/25/16 - Glenmark Pharma gets ANDA approval for Nystatin and Triamcinolone Acetonide Cream [India Infoline News Service]  Pharmacy Choice1 month ago
Money Control

Glenmark, Particle Sciences to develop generic cancer drug

Glenmark Pharmaceuticals today said it has entered into an agreement with US-based Particle Sciences Inc to develop and market a generic version of Celgene's ABRAXANE which is used in treatments of breast and lung cancers. The agreement for ...
 Business Standard2 months ago
India Infoline

Pharmaceuticals Newsletter - October 24 to 28, 2016

This week saw Glenmark Pharmaceuticals cons revenue up by 16% in Q2 FY17, Sun Pharmaceutical launched 4 generics in US. IIFL presents a weekly snapshot of all the major happenings in the Pharmaceuticals industry, nationally and internationally. ...
 India Infoline1 month ago

Glenmark appoints Dr. Kurt Stoeckli as President and Chief Scientific Officer

Dr. Stoeckli will lead the company's global research portfolio consisting of NBE, NCE, generics and branded formulations. He will be responsible for sustaining and enhancing the environment of collaborative research and for driving successful ...
 India Infoline1 month ago Glenmark appoints Dr Kurt Stoeckli as president & CSO  PharmaBiz1 month ago

Sanofi et al. v. Glenmark Pharmaceuticals, Inc. USA et al.

D. Del. (2016) On August 31, 2016, Judge Richard G. Andrews of the District of Delaware ruled in favor of Fitzpatrick's client Sanofi,upholding the validity of U.S. Patent No. 8,410,167. The 167 patent is directed to the use of Sanofi's Multaq® ...
 Fitzpatrickcella.com3 weeks ago GlaxoSmithKline LLC v. Teva Pharms. USA, Inc.  JD Supra3 weeks ago Sanofi v. Glenmark Pharms. Inc.  JD Supra1 month ago

U.S. Generic Drug Probe Takes Pharma Stocks Lower; Analysts Say Time To Buy

The biggest sectoral loser on Friday is the Nifty Pharma index, with all its ten constituents trading in the red, with losses of between 0.5-6 percent, reacting to a generic drug price probe that has been initiated by in the U.S.. The first charges ...
 Bloomberg-Quint1 month ago Range bound trading continues; pharma shares edge higher  Business Standard India3 weeks ago Indian pharmaceutical companies shares crash after reports of US probe into price collusion  The American Bazaar1 month ago Pharma stocks slide over US probe reports; Sun Pharma falls 7.41%  Livemint.com1 month ago

Global Digital Dose Inhaler (Branded Medication, Generics Medication) Market 2016-2024: Focus on Metered Dose Inhalers & Dry Powder Inhalers - Research and Markets

/PRNewswire/ -- has announced the addition of the report to their offering. The global digital dose inhaler market is anticipated to reach a value of USD 3.56 billion by 2024 The key factors contributing to the lucrative growth of this market ...
 International Business Times2 months ago Global Market for Pain Management - What's hot, what's not, what's next by coming years?  Before It's News1 week ago Anti-Infective Agents - Global Market Outlook (2016-2022)  MarketResearch.com4 weeks ago Market Research on Erythema Multiforme Global Clinical Trials Review, H2, 2016  MyNewsDesk1 month ago

DR.REDDY'S LABORATORIES LTD : Blog Coverage Dr. Reddy's Labs Launches Generic Osteoporosis Drug Tablets in the US

/ Active Wall St. blog coverage looks at the headline from Dr. Reddy's Laboratories Ltd (NYSE: RDY ) as the company announced on November 11, 2016, that it had launched a generic Osteoporosis drug, raloxifene hydrochloride, in tablet form in the US.
 4 Traders3 weeks ago Blog Coverage Dr. Reddy's Labs Launches Generic Osteoporosis Drug Tablets in the US  Yahoo! Finance3 weeks ago

PTAB Life Sciences Report -- Part I December 2016

About the PTAB Life Sciences Report: Each month we will report on developments at the PTAB involving life sciences patents. Mylan Pharmaceuticals Inc. v. Shire Laboratories, Inc. PTAB Petition: IPR2017-00011; filed October 4, 2016. Patent at ...
 JD Supra1 day ago PTAB Life Sciences Report - October 2016  JD Supra1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less